Élisa Gobbini
Université Claude Bernard Lyon 1(FR)Centre National de la Recherche Scientifique(FR)Inserm(FR)Centre Hospitalier Universitaire de Grenoble(FR)Centre Léon Bérard(FR)Centre de Recherche en Cancérologie de Lyon(FR)Institut Curie(FR)Institut Curie(FR)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment
Most-Cited Works
- → Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort(2018)277 cited
- → IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer(2020)136 cited
- → Immune Checkpoint Inhibitors Rechallenge Efficacy in Non–Small-Cell Lung Cancer Patients(2020)72 cited
- → Human Tumor-Infiltrating Dendritic Cells: From In Situ Visualization to High-Dimensional Analyses(2019)38 cited
- → Immune Checkpoint Inhibitor Rechallenge and Resumption: a Systematic Review(2022)36 cited
- → Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study(2017)36 cited